Search research articles
Contact Us
Filters
Showing results (51-60 of 289) with videos related to
Page
of 29
Sort By:
Cancer Treatment Reviews
|
March 1, 1990
Clinical applications of myeloid colony stimulating factors
W P Steward, N Thatcher, S B Kaye
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion
D Smith, J Wagstaff, N Thatcher, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 31, 2007
3-Hydroxy-4-methoxyindolomorphinans as delta opioid selective ligands
Trudy A Smith, Linn N Thatcher, Andrew Coop
Cancer
|
January 15, 1981
Effects of Corynebacterium parvum on cellular immunity of cancer patients, assayed sequentially over 63 days
N Thatcher, B Lamb, R Swindell, et al.
Magnetic Resonance Imaging
|
January 1, 1995
High-field MRS studies in brain slices
H Bachelard, P Morris, A Taylor, et al.
Anti-Cancer Drugs
|
May 1, 1996
Gemcitabine: once-weekly schedule active and better tolerated than twice-weekly schedule
C Martin, B Lund, H Anderson, et al.
Cancer Research
|
January 15, 1991
O6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine
S M Lee, N Thatcher, G P Margison
The British Journal of Dermatology
|
February 1, 1987
Multicentric reticulohistiocytosis
M O Coupe, S J Whittaker, N Thatcher
The Medical Journal of Australia
|
October 18, 1980
Unusual mycobacterium infection in a renal transplant recipient
M Moulsdale, J M Harper, G N Thatcher
British Medical Bulletin
|
July 1, 1995
Melanoma: chemotherapy
S M Lee, D C Betticher, N Thatcher
Page
of 29
Search research articles
Search
Showing results (51-60 of 289) with videos related to
Sort By:
Page
of 29
Cancer Treatment Reviews
|
March 1, 1990
Clinical applications of myeloid colony stimulating factors
W P Steward, N Thatcher, S B Kaye
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion
D Smith, J Wagstaff, N Thatcher, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 31, 2007
3-Hydroxy-4-methoxyindolomorphinans as delta opioid selective ligands
Trudy A Smith, Linn N Thatcher, Andrew Coop
Cancer
|
January 15, 1981
Effects of Corynebacterium parvum on cellular immunity of cancer patients, assayed sequentially over 63 days
N Thatcher, B Lamb, R Swindell, et al.
Magnetic Resonance Imaging
|
January 1, 1995
High-field MRS studies in brain slices
H Bachelard, P Morris, A Taylor, et al.
Anti-Cancer Drugs
|
May 1, 1996
Gemcitabine: once-weekly schedule active and better tolerated than twice-weekly schedule
C Martin, B Lund, H Anderson, et al.
Cancer Research
|
January 15, 1991
O6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine
S M Lee, N Thatcher, G P Margison
The British Journal of Dermatology
|
February 1, 1987
Multicentric reticulohistiocytosis
M O Coupe, S J Whittaker, N Thatcher
The Medical Journal of Australia
|
October 18, 1980
Unusual mycobacterium infection in a renal transplant recipient
M Moulsdale, J M Harper, G N Thatcher
British Medical Bulletin
|
July 1, 1995
Melanoma: chemotherapy
S M Lee, D C Betticher, N Thatcher
Page
of 29